Search

Meet Paul Yoon, Program Coordinator of Spiritual Care at Memorial Sloan Kettering, who immigrated to the US from South Korea, survived cancer, and is navigating his concerns around violence against Asian Americans.

… Friday, May 28, 2021 Compassion for self and others can heal the wounds we carry. It’s a profound lesson that Paul Yoon ,  Program Coordinator of Spiritual Care at Memorial Sloan Kettering ,   has learned and embraced through some of his most difficult life experiences — from immigrating to the US from

A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the study's findings, researchers identified the genetic pathway used to maintain a cell's quiescence, a state that allows bone marrow cells to escape the lethal effects of standard cancer treatments.

… Friday, January 9, 2009 A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the study’s findings, researchers identified the genetic

The combination of nivolumab (Opdivo®) and ipilimumab (Yervoy®) has shown improved progression-free survival (PFS) compared with chemotherapy as a first-line treatment for people with a high tumor mutational burden (TMB) in advanced non-small cell lung cancer (NSCLC). Data from the CheckMate -227 trial is being reported by Matthew Hellmann, MD, of Memorial Sloan Kettering Cancer Center, at the AACR Annual Meeting 2018. This research is featured in the meeting’s press program, and findings are being presented in the Clinical Trials Plenary Session, “Immunotherapy Combinations: The New Frontier in Lung Cancer.”

… Monday, April 16, 2018 The combination of nivolumab (Opdivo ® ) and ipilimumab (Yervoy ® ) has shown improved progression-free survival (PFS) compared with chemotherapy as a first-line treatment for people with a high tumor mutational burden (TMB) in advanced non-small cell lung cancer (NSCLC). Data

New research funds have been awarded by the RSNA Research & Education Foundation to Robert Young, MD for Using Functional MRI and Diffusion Tensor Imaging of the Language Pathway to Optimize Brain Tumor Resection.

… Monday, June 13, 2011 New research funds have been awarded by the RSNA Research & Education Foundation to Robert Young, MD for  Using Functional MRI and Diffusion Tensor Imaging of the Language Pathway to Optimize Brain Tumor Resection .

GSK’s Fourth Biennial Retreat on May 6 and 7 at the Mohonk Mountain House in New Paltz, New York, will feature former Sloan Kettering Institute Director Dr. Thomas J. Kelly.

… Monday, May 2, 2016 The Gerstner Sloan Kettering Graduate School of Biomedical Sciences’ fourth Biennial Retreat will take place from May 6 through May 7, 2016, at the Mohonk Mountain House in New Paltz, New York. The retreat will celebrate the first decade of matriculants in GSK’s graduate program.

Memorial Sloan Kettering Cancer Center announced it has selected Epic to provide a new platform for integrated care that will ensure patients and physicians can more easily access electronic health records.

… Monday, November 21, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced it has selected Epic to provide a new platform for integrated care that will ensure patients and physicians can more easily access electronic health records (EHR). Implementing Epic is an important milestone that will

Memorial Sloan Kettering Cancer Center physician-scientists report that women with small, node-negative, HER2-positive breast cancer may obtain a significant benefit from adjuvant chemotherapy with trastuzumab (Herceptin®), a drug previously shown to improve outcomes in advanced cancer and prevent the return of cancer in women diagnosed with higher-risk, early-stage, HER2-positive breast cancer. This study appears online in the journal Cancer, and will be published in a future print edition.

… Friday, June 24, 2011 Memorial Sloan Kettering Cancer Center physician-scientists report that women with small, node-negative, HER2 -positive breast cancer may obtain a significant benefit from adjuvant chemotherapy with trastuzumab (Herceptin ® ), a drug previously shown to improve outcomes in advanced

Learn how MSK’s Antibiotic Management Program is leading the way in ensuring that antibiotics and other antimicrobial drugs are used responsibly.

… Wednesday, May 22, 2019 Summary In this Q & A, infectious disease expert Susan Seo discusses MSK’s Antibiotic Management Program. It ensures that antibiotics and other antimicrobial drugs are used responsibly. The rapid emergence of drug-resistant microorganisms is “a global crisis that threatens a century

MSK is proud to announce that four Sloan Kettering Institute (SKI) researchers have been named 2024 Marie-Josée Kravis Women in Science Endeavor (Kravis WISE) fellowship grant recipients.

… Thursday, February 29, 2024 Each year, the Marie-Josée Kravis Women in Science Endeavor (WISE) initiative awards several fellowships to female graduate students and postdoctoral fellows to support their research at Memorial Sloan Kettering Cancer Center (MSK). The awards are announced in March, to coincide

… Wednesday, March 5, 2025 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce a new community mural, “One Hundred Views,” by artist Naomi Reis. The inaugural MSK mural was created in collaboration with fifth-grade students from  P.S. 183 Robert L. Stevenson Elementary School , the neighboring